3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
6
Lung Neoplasms
5
Colorectal Neoplasms
5
Prostatic Neoplasms
4
Motor Activity
3
Hodgkin Disease
2
Hematopoietic and Lymphoid System Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Stress Disorders, Post-Traumatic
1
Sleep Wake Disorders
1
Sedentary Behavior
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Pathologically Proven Gastrointestinal Malignancy
1
Obesity
1
Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Insulin Resistance
1
Inflammatory Breast Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
Interventions
Metformin
149
Clomiphene
50
Letrozole
38
Inositol
34
Folic Acid
18
Exercise
17
Progesterone
15
Ethinyl Estradiol
13
Chorionic Gonadotropin
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Estradiol
12
Contraceptives, Oral
11
cetrorelix
10
Pioglitazone
10
High-Intensity Interval Training
10
Tablets
9
Spironolactone
9
Cholecalciferol
9
Triptorelin Pamoate
8
Diet
8
Vitamin D
7
Thioctic Acid
7
Menotropins
7
Liraglutide
7
Acupuncture Therapy
7
drospirenone
6
Ovidrel
6
Gonadotropins
6
Flutamide
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Polycystic Ovary Syndrome
×
Exercise Test
×
Clear all
NCT05215223
2023-10-17
WBV
Cairo University
Phase NA
Completed
46 enrolled